FindTrial
Sign In

Establishment and external validation of a predictive model for cerebrospinal fluid rhinorrhea after endoscopic endonasal pituitary tumor resection

Establishment and external validation of a predictive model for cerebrospinal fluid rhinorrhea after endoscopic endonasal pituitary tumor resection

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300072731
Enrollment
Unknown
Registered
2023-06-23
Start date
2023-06-23
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pituitary adenoma

Interventions

training cohort:no
validation cohort:no

Sponsors

Shenzhen Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Older than 18 years; The sellar region lesions were found by enhanced MRI or dynamic MRI scanning in our hospital. Patients with surgical indications underwent endoscopic endonasal transsphenoidal pituitary adenoma resection; Pituitary adenoma was confirmed by postoperative pathology

Exclusion criteria

Exclusion criteria: Patients with other brain tumors; Patients with missing basic information, medical data and imaging data; Patients with malignant tumors, severe heart failure, cirrhosis and liver failure; Patients who were lost to follow-up

Design outcomes

Primary

MeasureTime frame
cerebrospinal fluid leakage within 30 days after surgery;—

Secondary

MeasureTime frame
Intraoperative cerebrospinal fluid leakage;—

Countries

China

Contacts

Public ContactYufei Liu

Shenzhen Second People's Hospital

471879610@qq.com+86 134 2424 5562

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026